Personal

NxThera’s founder, Michael Hoey’s father died of prostate cancer in 1995. NxThera’s products are
being designed to honor his memory. Michael is personally and passionately dedicated to finding
humane and effective treatments for prostate and other endourologic conditions.

Dedicated to Francis Hoey

Innovative

A few drops of water converted to vapor may hold enough stored energy to treat benign prostatic
hyperplasia, prostate cancer and kidney cancer. NxThera’s Convective WAVE™ Technology is currently in clinical
testing and is designed to be the next generation of minimally invasive treatments for endourologic conditions.

Transformative

An overwhelming majority of patients across the globe are looking for alternative treatment options for prostate and other endourologic conditions. NxThera is working on solutions that are designed to transform the treatment experience for both patients and physicians.

*CAUTION FOR U.S. ONLY – Investigational Device. Limited by United States Federal Law to Investigational Use. The Rezum System is not cleared or approved for any use by the FDA. It is currently available for investigational use only under an IDE approved by the FDA.